A Case of Pediatric Nephrolithiasis Associated with Topiramate Treatment.
- Author:
Kyung Taek HONG
1
;
Hye Won RYU
;
Kihyun DOO
;
Jae So CHO
;
Anna CHO
;
Byung Chan LIM
;
Jong Hee CHAE
;
Ki Joong KIM
;
Yong Seung HWANG
;
Hee HWANG
Author Information
1. Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. neuroandy@korea.com
- Publication Type:Case Report
- Keywords:
Topiramate;
Nephrolithiasis;
Antiepileptics;
Side effects
- MeSH:
Anticonvulsants;
Fructose;
Humans;
Migraine Disorders;
Mood Disorders;
Nephrolithiasis;
Seizures
- From:
Journal of the Korean Child Neurology Society
2010;18(1):112-116
- CountryRepublic of Korea
- Language:English
-
Abstract:
Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
